Page 10 - Astrazeneca

Germany to discuss AstraZeneca Covid-19 shots after blood clot reports

Health Minister Jens Spahn will talk with his regional counterparts at 1800 CET (1600 GMT), a ministry spokesman said

Finland resumes use of AstraZeneca's Covid vaccine for people above 65 yrs

Finland has resumed the use of the AstraZeneca Covid-19 vaccine, but only for people over the age of 65, as per the guidelines issued by the Finnish Institute for Health and Welfare

Canadian panel recommends AstraZeneca vaccine pause for under 55

Canada's National Advisory Committee on Immunisation is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons

Coronavirus vaccine: Germany reports more AstraZeneca clot cases

Germany's medical regulator says it has received reports of 21 cases of rare blood clots in people who had recently received AstraZeneca's coronavirus vaccine.

Top headlines: SC 'unseats' minority shareholders; vax makers seek govt aid

The price of the AstraZeneca vaccine - the one sold the most globally- varies from $2 to $6 per dose. India has got this vaccine at $2.06 per dose, the cheapest in the world. Read today's top news

At $2.06 per dose, India pays the least for AstraZeneca Covid-19 vaccine

The price paid by different governments for a vaccine dose - including for the same vaccine - varies across countries, Unicef data shows

SII, Bharat Bio seek central fund injection to ramp up vaccine production

SII, Bharat Biotech want to increase production to meet domestic, foreign demand

AstraZeneca updates Covid-19 vaccine efficacy rate to 76%

AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trial

AstraZeneca says its coronavirus vaccine 76% effective in US phase-3 trial

This new efficacy analysis included the accrual of 190 symptomatic cases of Covid-19

AstraZeneca confirms its Covid vaccine is strongly effective after US rift

AstraZeneca insisted its Covid-19 vaccine is strongly effective even after counting additional illnesses in its disputed US study, the latest in an extraordinary public rift with American officials

India delays big exports of AstraZeneca shot as infections surge: Report

COVAX has a deal to buy 1.1 billion doses of the AstraZeneca and Novavax shots that the SII is making in bulk, mainly for low- and middle-income countries.

AstraZeneca to publish US trial results after rebuke over outdated data

AstraZeneca will publish up-to-date results from its US trial within 48 hours after health officials publicly criticised it for using "outdated information" to show how well the immunisation worked

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority

Building back worse

The UK urgently needs a dynamic, entrepreneurial mission-setting state to confront the triple crisis of Covid-19, rising inequality, and climate change

Reputation of AstraZeneca's Covid-19 vaccine marred by missteps

AstraZeneca's release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it.

AstraZeneca may have used outdated info in coronavirus vaccine trial: US

Results from a US trial of AstraZeneca's Covid-19 vaccine may have used "outdated information," US federal health officials said in a statement early Tuesday

Spain broadens use of AstraZeneca's Covid jab to adults under age of 65

Spain's health minister has said the country will resume the use of the AstraZeneca coronavirus vaccine on Wednesday by extending it to adults under the age of 65

AstraZeneca US trial shows 79% efficacy against Covid-19 pandemic

Trial found no increased risk of blood clots

One year on

Ravages of last year's lockdown may still affect economy

AstraZeneca says US trial data shows Covid-19 vaccine 79% effective

AstraZeneca says advanced trial data from a US study on its Covid-19 vaccine shows it is 79 per cent effective